Drawing for Serial No. 79275300

USPTO serial 79275300

Serial No. 79275300

Reviewed by CopyMark Law Group

Reg. 6182144Status 700Renewal
Filing date
Status date
Registration date
Oct 27, 2020
Examiner
PARKS, KIMBERLY L
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 79275300?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $850

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Chinhwei Chen

Chinhwei Chen Jianq Chyun Intellectual Property Office7F.-1, No. 100, Roosevelt Rd. Sec. 2Taipei, 10084TAIWAN

Goods and services

ClassDescriptionStatusFirst use
005Herbal teas for medicinal purposes; Medicine for human purpose for the treatment of gastrointestinal system, respiratory system, genitourinary system, endocrine system, nervous system, circulatory system and musculoskeletal system related diseases and for the treatment of colds and flu, skin diseases, tumors, dental and oral diseases; Nutritive substance for microorganisms for medical purposes; Capsules sold empty for medicines; Medicinal herbal tea; Chinese patent medicines for the treatment of gastrointestinal system, respiratory system, genitourinary system, endocrine system, nervous system, circulatory system and musculoskeletal system related diseases and for the treatment of colds and flu, skin diseases, tumors, dental and oral diseases; Injectable solutions for medical purposes for treating gastrointestinal system, respiratory system, genitourinary system, endocrine system, nervous system, circulatory system and musculoskeletal system related diseases and for the treatment of colds and flu, skin diseases, tumors, dental and oral diseases; diet teas for medical purpose; medicated liquor; disinfectants; powdered milk for babies; dietetic substances adapted for medical use; air purifying preparations; Medicines for veterinary purposes for treating antimicrobial and anti-parasitic treatment, for promoting growth of animals and for the treatment of nervous, gastrointestinal, respiratory and metabolic system related diseases; vermin destroying preparations; mosquito-repellent incenses; preparations for destroying noxious animals; adhesive tapes for medical purposes; tissues impregnated with pharmaceutical lotions; teeth filling material; medicinal drinks; Pharmaceutical preparations for treating gastrointestinal system, respiratory system, genitourinary system, endocrine system, nervous system, circulatory system and musculoskeletal system related diseases and for the treatment of colds and flu, skin diseases, tumors, dental and oral diseases; Decoctions for pharmaceutical purpose for treating gastrointestinal system, respiratory system, genitourinary system, endocrine system, nervous system, circulatory system and musculoskeletal system related diseases and for the treatment of colds and flu, skin diseases, tumors, dental and oral diseases; digestives for pharmaceutical purposes; Active pharmaceutical ingredients, namely, pharmaceutical preparations for treating gastrointestinal system, respiratory system, genitourinary system, endocrine system, nervous system, circulatory system and musculoskeletal system related diseases and for the treatment of colds and flu, skin diseases, tumors, dental and oral diseases; Radioactive pharmaceuticals for treating gastrointestinal system, respiratory system, genitourinary system, endocrine system, nervous system, circulatory system and musculoskeletal system related diseases and for the treatment of colds and flu, skin diseases, tumors, dental and oral diseases; gases for medical purposes; chemical conductors for electrocardiograph electrodes; semen for artificial insemination; solutions for contact lenses; media for bacteriological cultures; candy, medicated; chewing gum for medical purposesACTIVE—
030Cocoa preparations, namely, cocoa, cocoa powder; tea-based beverages; tea substitutes; sugar; ginseng candy; herbal jelly candy; instant edible bird's nest with sugar; loquat paste being fruit paste for flavoring food; confectionery, namely, candy; cooking salt; yeast; food flavorings being non-essential oils in the nature of citrus, fruit, mint, bean, spicy, milk flavor, meat flavor, nut, wine and vegetable essences for foodstuffs, except etheric essences and essential oils; vegetal preparations for use as coffee substitutes; tea; peppermint sweets; royal jelly for food purposes; breakfast cereal consisting of dried fruit and nuts; Processed cereal powder-based food; cereal preparations, namely, cereal bars; noodle-based prepared meals; cereal-based snack food; bean flour; starch for food; edible ices; vinegar; seasonings; gluten prepared as foodstuff for culinary purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 27, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Apr 23, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 21, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 9, 2021XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Feb 9, 2021XXCRGENERIC MADRID TRANSACTION CREATED—
Jan 27, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 8, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 27, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 11, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 11, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 7, 2020GPNXNOTIFICATION PROCESSED BY IB—
Jul 22, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 22, 2020OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 22, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 7, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 6, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 6, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 6, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 16, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 16, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 16, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 16, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 16, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 22, 2020RFNTREFUSAL PROCESSED BY IB—
Feb 6, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 6, 2020RFRRREFUSAL PROCESSED BY MPU—
Jan 14, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 13, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 11, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 7, 2020DOCKASSIGNED TO EXAMINER—
Jan 7, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 26, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance